SARS-CoV-2 Exposure Elicits a Strong Mucosal Antibody Response That May Facilitate Quicker Mucosal Viral Clearance
Viruses · 2026
DOI: 10.3390/v18091034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Muruganantham Lillimary Eniya und 21 weiteren Autor:innen. Beteiligte Einrichtung: VHS Laboratory Services, Department of Clinical Research, The Voluntary Health Services, Chennai 600113, India. Hauptthemen laut MEDLINE: Antibodies, Viral, COVID-19, SARS-CoV-2, Immunity, Mucosal. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI, DBT.
Abstract (Originalsprache)
The entry of SARS-CoV-2 via the mucosal surfaces of the upper respiratory tract, including the oral cavity, may be influenced by innate and adaptive immunity. We aimed to determine whether antibodies in secretions might influence the SARS-CoV-2 burden and thus the severity of infection. Blood and stimulated oral fluid (SOF) samples were collected at recruitment (d0) from 173 participants and sequentially at d14, d30 and d90 from 52 participants. Anti-SARS-CoV-2 spike antibodies of the IgG, IgA and SIgA isotypes were detected by ELISA. SARS-CoV-2 RNA copies were quantified by RT-PCR. SARS-CoV-2 RNA copies became negative by d14 in most subjects. At d14, 5/18 SOF samples continued to be RT-PCR-positive. Serum/SOF IgG antibodies were detected in all patients; IgG/IgA/SIgA antibodies increased by d14 and decreased by d90. At d0 and d14, SOF RNA copies were negatively correlated with SOF/serum IgG and with SOF IgA/SIgA antibodies. Higher SOF antibodies were significantly associated with a more rapid decline in SARS-CoV-2 burden. SARS-CoV-2 RNA copies and spike-specific antibodies showed differential trends during the major and minor COVID-19 waves in India. Avidity indices for SOF IgG/IgA antibodies declined by d90. Taken together, our data suggest a potential functional role for SOF anti-SARS-CoV-2 spike antibodies in clearing SARS-CoV-2 from the oral mucosa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- VHS Laboratory Services, Department of Clinical Research, The Voluntary Health Services, Chennai 600113, India.
- Centre for Host Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, Floor 17, Guy's Hospital Tower, King's College London, London SE1 9RT, UK.
- Chennai Dental Research Foundation, Chennai 600004, India.
- Ragas Dental College and Hospital, Chennai 600119, India.
- Griffith University Dental School, Southport, QLD 4215, Australia.
ORCID-Profile: Muruganantham Lillimary Eniya, Selvamuthu Poongulali, Chandra Lavanya, Kannan Ranganathan, Gunaseelan Rajan, David Moyes, Mark Ide, Newell Johnson, Stephen Challacombe
Förderung
- UKRI
- DBT
Zitieren
APA
Eniya, M. L., Nasab, S. D. S., Judith, A., Clasen, F., Faith, B., Poongulali, S., Gita, J. B., Ashok, C., Raghavi, V., Vedavalli, S., Lavanya, C., Ranganathan, K., Rajan, G., Kumarasamy, N., Moyes, D., Ide, M., Shoaie, S., Kurushima, Y., Jagdev, D., …, & Kannian, P. (2026). SARS-CoV-2 Exposure Elicits a Strong Mucosal Antibody Response That May Facilitate Quicker Mucosal Viral Clearance. Viruses. https://doi.org/10.3390/v18091034
Vancouver
Eniya ML, Nasab SDS, Judith A, Clasen F, Faith B, Poongulali S, et al. SARS-CoV-2 Exposure Elicits a Strong Mucosal Antibody Response That May Facilitate Quicker Mucosal Viral Clearance. Viruses. 2026. doi:10.3390/v18091034
BibTeX
@article{Eniya2026,
author = {Eniya, Muruganantham Lillimary and Nasab, Shervin Dokht Sadeghi and Judith, Albert and Clasen, Frederick and Faith, Beulah and Poongulali, Selvamuthu and Gita, Jayaraman Bhagavad and Ashok, Chakrapani and Raghavi, Velmurugan and Vedavalli, Subramanian and Lavanya, Chandra and Ranganathan, Kannan and Rajan, Gunaseelan and Kumarasamy, Nagalingeswaran and Moyes, David and Ide, Mark and Shoaie, Saeed and Kurushima, Yuko and Jagdev, Daljit and Johnson, Newell and Challacombe, Stephen and Kannian, Priya},
title = {SARS-CoV-2 Exposure Elicits a Strong Mucosal Antibody Response That May Facilitate Quicker Mucosal Viral Clearance},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18091034}
}
EUVIMED